Miltenyi Biotec Nordics Becomes a Trusted Partner of the Flemingsberg Science Foundation

Flemingsberg 2024-12-13

Today the Flemingsberg Science Foundation announces that Miltenyi Biotec Nordics has become a Trusted Partner, entering into a strategic collaboration aimed at promoting and strengthening the development of ATMP (Advanced Therapy Medicinal Products) and the Life Science sector in Flemingsberg.

With the rapid development of ATMP in Flemingsberg, the foundation seeks to create a strong support network for individuals and companies within Life Science. Through this partnership with Miltenyi Biotec Nordics, we are taking another significant step towards building a robust infrastructure for innovation and growth in the region.

“By partnering with a global biotechnology company like Miltenyi, we are creating entirely new conditions to establish the best possible ecosystem for advanced therapies. Through the events and idea development discussions already conducted with Miltenyi, I know that this is just the beginning of the journey.” – Johnny Högberg, CEO of the Flemingsberg Science Foundation.

As a Trusted Partner, Miltenyi Biotec Nordics will play a key role in organizing a flagship ATMP event and further enhancing the lecture series “Hitchhiker’s Guide to Startup Success” for the Flemingsberg Innovation Community. With their presence in Flemingsberg, they can seamlessly and efficiently address the specific needs of companies and organizations within the ATMP sector.

“Getting new ATMPs from the research lab to the reality of the patient bedside is only possible with an engaged and supportive ATMP community. We are therefore excited to partner with Flemingsberg Science Foundation, as stakeholders with a shared vision of treating more patients in Sweden.” -Thomas Kjaer Mogensen, Miltenyi Biotec Nordics.

We hope that more will join us as Trusted Partners. If you are someone who can contribute to strengthening the innovation environment and business climate in Flemingsberg, don’t hesitate to get in touch!

Johnny Högberg
CEO Flemingsberg Science Foundation
johnny.hogberg@flemingsbergscience.se
070 550 12 73

AlzeCure Pharma – a hope in the fight against Alzheimer’s

Neurological diseases and the pain area are struggling with great medical needs, including the lack of broad-spectrum drugs. Those are gaps in the market that AlzeCure Pharma wants to fill, and they are well on their way. They recently received a grant from the European Innovation Council (EIC) to finance a clinical phase 2 study of the drug candidate NeuroRestore ACD856 for Alzheimer’s disease.

Kick-off Cluster Engine Life Science Flemingsberg!

At the end of last year, the Flemingsberg Science Foundation was granted funding from the European Regional Development Fund (ERDF) for the project Cluster Engine Life Science Flemingsberg, which aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. Recently, it was time for the official launch – and what a grand launch it was!

Flemingsberg Expands with Huge Bostäder

Imagine a home where The Royal Swedish Opera and The Royal Dramatic Theatre’s studios are in your front yard, and the Flemingsberg Forest Nature Reserve and Lake Gömmaren are in your back yard. Where Campus Flemingsberg is your neighbor to the left, and a modernized shopping center your neighbor to the right. Too good to be true? Not at all!

12 Next